These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35896334)

  • 1. An Engineered Monovalent Anti-TNF-α Antibody with pH-Sensitive Binding Abrogates Immunogenicity in Mice following a Single Intravenous Dose.
    Watkins JM; Watkins JD
    J Immunol; 2022 Aug; 209(4):829-839. PubMed ID: 35896334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti-TNF-α Antibodies after a Single Injection in Mice.
    Arnoult C; Brachet G; Cadena Castaneda D; Azzopardi N; Passot C; Desvignes C; Paintaud G; Heuzé-Vourc'h N; Watier H; Gouilleux-Gruart V
    J Immunol; 2017 Jul; 199(2):418-424. PubMed ID: 28584008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor.
    Kaymakcalan Z; Sakorafas P; Bose S; Scesney S; Xiong L; Hanzatian DK; Salfeld J; Sasso EH
    Clin Immunol; 2009 May; 131(2):308-16. PubMed ID: 19188093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAII peptide presentation of infliximab increases when complexed with TNF.
    Casasola-LaMacchia A; Seward RJ; Tourdot S; Willetts M; Kruppa G; Agostino MJ; Bergeron G; Ahyi-Amendah N; Ciarla A; Lu Z; Kim HY; Hickling TP; Neubert H
    Front Immunol; 2022; 13():932252. PubMed ID: 36177046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.
    Chanchlani N; Lin S; Auth MK; Lee CL; Robbins H; Looi S; Murugesan SV; Riley T; Preston C; Stephenson S; Cardozo W; Sonwalkar SA; Allah-Ditta M; Mansfield L; Durai D; Baker M; London I; London E; Gupta S; Di Mambro A; Murphy A; Gaynor E; Jones KDJ; Claridge A; Sebastian S; Ramachandran S; Selinger CP; Borg-Bartolo SP; Knight P; Sprakes MB; Burton J; Kane P; Lupton S; Fletcher A; Gaya DR; Colbert R; Seenan JP; MacDonald J; Lynch L; McLachlan I; Shields S; Hansen R; Gervais L; Jere M; Akhtar M; Black K; Henderson P; Russell RK; Lees CW; Derikx LAAP; Lockett M; Betteridge F; De Silva A; Hussenbux A; Beckly J; Bendall O; Hart JW; Thomas A; Hamilton B; Gordon C; Chee D; McDonald TJ; Nice R; Parkinson M; Gardner-Thorpe H; Butterworth JR; Javed A; Al-Shakhshir S; Yadagiri R; Maher S; Pollok RCG; Ng T; Appiahene P; Donovan F; Lok J; Chandy R; Jagdish R; Baig D; Mahmood Z; Marsh L; Moss A; Abdulgader A; Kitchin A; Walker GJ; George B; Lim YH; Gulliver J; Bloom S; Theaker H; Carlson S; Cummings JRF; Livingstone R; Beale A; Carter JO; Bell A; Coulter A; Snook J; Stone H; Kennedy NA; Goodhand JR; Ahmad T;
    Aliment Pharmacol Ther; 2022 Oct; 56(8):1250-1263. PubMed ID: 36039036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic Cells.
    Wawrzyniak M; Morsy Y; Mladenov R; Tontodonati G; Turgay Y; Herwig S; Back J; Mally M; Faridmoayer A; Scharl M
    J Crohns Colitis; 2021 Sep; 15(9):1596-1601. PubMed ID: 33631789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments.
    Krayukhina E; Noda M; Ishii K; Maruno T; Wakabayashi H; Tada M; Suzuki T; Ishii-Watabe A; Kato M; Uchiyama S
    MAbs; 2017; 9(4):664-679. PubMed ID: 28387583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
    Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
    Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane TNF-α Reverse Signaling Inhibits Lipopolysaccharide-Induced Proinflammatory Cytokine Formation in Macrophages by Inducing TGF-β: Therapeutic Implications.
    Pallai A; Kiss B; Vereb G; Armaka M; Kollias G; Szekanecz Z; Szondy Z
    J Immunol; 2016 Feb; 196(3):1146-57. PubMed ID: 26729808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane TNF-alpha reverse signaling leading to TGF-beta production is selectively activated by TNF targeting molecules: Therapeutic implications.
    Szondy Z; Pallai A
    Pharmacol Res; 2017 Jan; 115():124-132. PubMed ID: 27888159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-TNF Alpha Antibody Humira with pH-dependent Binding Characteristics: A constant-pH Molecular Dynamics, Gaussian Accelerated Molecular Dynamics, and In Vitro Study.
    Hong ST; Su YC; Wang YJ; Cheng TL; Wang YT
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo.
    Yu F; Gudmundsdotter L; Akal A; Gunneriusson E; Frejd F; Nygren PÅ
    MAbs; 2014; 6(6):1598-607. PubMed ID: 25484067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro.
    Yamaguchi M; Murakami T; Tomimatsu T; Nishio Y; Mitsuda N; Kanzaki T; Kurachi H; Shima K; Aono T; Murata Y
    Biochem Biophys Res Commun; 1998 Mar; 244(1):30-4. PubMed ID: 9514868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
    Kennedy NA; Heap GA; Green HD; Hamilton B; Bewshea C; Walker GJ; Thomas A; Nice R; Perry MH; Bouri S; Chanchlani N; Heerasing NM; Hendy P; Lin S; Gaya DR; Cummings JRF; Selinger CP; Lees CW; Hart AL; Parkes M; Sebastian S; Mansfield JC; Irving PM; Lindsay J; Russell RK; McDonald TJ; McGovern D; Goodhand JR; Ahmad T;
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):341-353. PubMed ID: 30824404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis.
    van Schouwenburg PA; Rispens T; Wolbink GJ
    Nat Rev Rheumatol; 2013 Mar; 9(3):164-72. PubMed ID: 23399692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization and rapid recycling of macrophage Fc receptors tagged with monovalent antireceptor antibody: possible role of a prelysosomal compartment.
    Mellman I; Plutner H; Ukkonen P
    J Cell Biol; 1984 Apr; 98(4):1163-9. PubMed ID: 6715403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants.
    Ameloot P; Fiers W; De Bleser P; Ware CF; Vandenabeele P; Brouckaert P
    J Biol Chem; 2001 Oct; 276(40):37426-30. PubMed ID: 11448951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD.
    Frederiksen MT; Ainsworth MA; Brynskov J; Thomsen OO; Bendtzen K; Steenholdt C
    Inflamm Bowel Dis; 2014 Oct; 20(10):1714-21. PubMed ID: 25069030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors.
    Smith RA; Kirstein M; Fiers W; Baglioni C
    J Biol Chem; 1986 Nov; 261(32):14871-4. PubMed ID: 3021754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of adalimumab in paediatric Crohn's disease patients naïve to other anti-TNF therapies.
    Martín-de-Carpi J; Pociello N; Varea V
    J Crohns Colitis; 2010 Nov; 4(5):594-8. PubMed ID: 21122566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.